Brain MR Spectroscopic Findings in 3 Consecutive Patients with COVID-19: Preliminary Observations

References

1. 1.↵
   1. Cucinotta D,
   2. Vanelli M

   . WHO declares COVID-19 a pandemic. Acta Biomed 2020;91:157–60 doi:10.23750/abm.v91i1.9397 pmid:32191675

   CrossRefPubMed
2. 2.↵
   1. Berlin DA,
   2. Gulick RM,
   3. Martinez FJ

   . Severe Covid-19. N Engl J Med 2020 May 15. [Epub ahead of print] doi:10.1056/NEJMcp2009575 pmid:32412710

   CrossRefPubMed
3. 3.↵
   1. Romero-Sanchez CM,
   2. Diaz-Maroto I,
   3. Fernandez-Diaz E, et al

   . Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology 2020;95:e1060–70 doi:10.1212/WNL.0000000000009937 pmid:32482845

   Abstract/FREE Full Text
4. 4.↵
   1. Helms J,
   2. Kremer S,
   3. Merdji H, et al

   . Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020;382:2268–70 doi:10.1056/NEJMc2008597 pmid:32294339

   CrossRefPubMed
5. 5.↵
   1. Couzin-Frankel J

   . The mystery of the pandemic’s ‘happy hypoxia.’ Science 2020;368:455–56 doi:10.1126/science.368.6490.455 pmid:32355007

   Abstract/FREE Full Text
6. 6.↵
   1. Solomon IH,
   2. Normandin E,
   3. Bhattacharyya S, et al

   . Neuropathological features of Covid-19. N Engl J Med 2020;383:989–92 doi:10.1056/NEJMc2019373 pmid:32530583

   CrossRefPubMed
7. 7.↵
   1. Sun J,
   2. Song H,
   3. Yang Y, et al

   . Metabolic changes in normal appearing white matter in multiple sclerosis patients using multivoxel magnetic resonance spectroscopy imaging. Medicine (Baltimore) 2017;96:e6534 doi:10.1097/MD.0000000000006534 pmid:28383419

   CrossRefPubMed
8. 8.↵
   1. Bizzi A,
   2. Castelli G,
   3. Bugiani M, et al

   . Classification of childhood white matter disorders using proton MR spectroscopic imaging. AJNR Am J Neuroradiol 2008;29:1270–75 doi:10.3174/ajnr.A1106 pmid:18483189

   Abstract/FREE Full Text
9. 9.↵
   1. Andronesi OC,
   2. Gagoski BA,
   3. Sorensen AG

   . Neurologic 3D MR spectroscopic imaging with low-power adiabatic pulses and fast spiral acquisition. Radiology 2012;262:647–61 doi:10.1148/radiol.11110277 pmid:22187628

   CrossRefPubMed
10. 10.↵
    1. Provencher SW

    . Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001;14:260–64 doi:10.1002/nbm.698 pmid:11410943

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Radmanesh A,
    2. Derman A,
    3. Lui YW, et al

    . COVID-19-associated diffuse leukoencephalopathy and microhemorrhages. Radiology 2020 May 21. [Epub ahead of print] doi:10.1148/radiol.2020202040 pmid:32437314

    CrossRefPubMed
12. 12.↵
    1. Sachs JR,
    2. Gibbs KW,
    3. Swor DE, et al

    . COVID-19-associated leukoencephalopathy. Radiology 2020;296:E184–85 doi:10.1148/radiol.2020201753 pmid:32407258

    CrossRefPubMed
13. 13.↵
    1. Beeskow AB,
    2. Oberstadt M,
    3. Saur D, et al

    . Delayed post-hypoxic leukoencephalopathy (DPHL): an uncommon variant of hypoxic brain damage in adults. Front Neurol 2018;9:708 doi:10.3389/fneur.2018.00708 pmid:30210433

    CrossRefPubMed
14. 14.↵
    1. Shprecher DR,
    2. Flanigan KM,
    3. Smith AG, et al

    . Clinical and diagnostic features of delayed hypoxic leukoencephalopathy. J Neuropsychiatry Clin Neurosci 2008;20:473–77 doi:10.1176/jnp.2008.20.4.473 pmid:19196933

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Terajima K,
    2. Igarashi H,
    3. Hirose M, et al

    . Serial assessments of delayed encephalopathy after carbon monoxide poisoning using magnetic resonance spectroscopy and diffusion tensor imaging on 3.0T system. Eur Neurol 2008;59:55–61 doi:10.1159/000109262 pmid:17917459

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Reichard RR,
    2. Kashani KB,
    3. Boire NA, et al

    . Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol 2020;140:1–6 doi:10.1007/s00401-020-02166-2 pmid:32449057

    CrossRefPubMed
17. 17.↵
    1. Brenner RE,
    2. Munro PM,
    3. Williams SC, et al

    . The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med 1993;29:737–45 doi:10.1002/mrm.1910290605 pmid:8350716

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Bitsch A,
    2. Bruhn H,
    3. Vougioukas V, et al

    . Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999;20:1619–27 pmid:10543631

    Abstract/FREE Full Text
19. 19.↵
    1. Takanashi JI,
    2. Murofushi Y,
    3. Hirai N, et al

    . Prognostic value of MR spectroscopy in patients with acute excitotoxic encephalopathy. J Neurol Sci 2020;408:116636 doi:10.1016/j.jns.2019.116636 pmid:31879119

    CrossRefPubMed
20. 20.↵
    1. Kamate M

    . Acute leukoencephalopathy with restricted diffusion. Indian J Crit Care Med 2018;22:519–23 doi:10.4103/ijccm.IJCCM_139_18 pmid:30111927

    CrossRefPubMed
21. 21.↵
    1. Premji S,
    2. Kang L,
    3. Rojiani MV, et al

    . Multifocal necrotizing leukoencephalopathy: expanding the clinicopathologic spectrum. J Neuropathol Exp Neurol 2019;78:340–47 doi:10.1093/jnen/nlz003 pmid:30753632

    CrossRefPubMed
22. 22.↵
    1. Raghavendra S,
    2. Nair MD,
    3. Chemmanam T, et al

    . Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate. Eur J Neurol 2007;14:309–14 doi:10.1111/j.1468-1331.2006.01659.x pmid:17355553

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Aydin H,
    2. Ozgul E,
    3. Agildere AM

    . Acute necrotizing encephalopathy secondary to diphtheria, tetanus toxoid and whole-cell pertussis vaccination: diffusion-weighted imaging and proton MR spectroscopy findings. Pediatr Radiol 2010;40:1281–84 doi:10.1007/s00247-009-1498-9 pmid:20119724

    CrossRefPubMed